文献速递外周动脉疾病

基于TASC II膝下动脉分类的严重肢体缺血患者膝下介入治疗中期结局

Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries.
PubMed 文献 · J Endovasc Ther · 2017-04-19

单中心回顾性研究纳入166例严重肢体缺血患者、244处膝下病变,比较TASC A/B与C/D病变的结局。C/D组截肢率更高、主要不良肢体事件更多、一期通畅率更低,但3年生存率无差异。

要点

  • TASC C/D膝下病变3年免截肢率67% vs A/B组85%。
  • TASC C/D组3年免于主要不良肢体事件率61% vs A/B组79%。
  • TASC A/B组技术成功率和1年一期通畅率更高。

核心结论

  • TASC C/D膝下病变与更高的截肢率和主要不良肢体事件率相关,且一期通畅率低于TASC A/B病变。

研究设计与样本

  • 单中心回顾性研究纳入2006至2013年166例连续严重肢体缺血患者(平均年龄71岁,113例男性),共244处膝下病变接受腔内治疗。

主要发现

  • TASC A/B病变较短(53±35 vs 170±83 mm,p<0.001)、狭窄程度较轻(77%±24% vs 93%±14%,p<0.001)、靶血管直径较大(2.9±0.5 vs 2.6±0.5 mm,p<0.001),慢性完全闭塞较少(24% vs 64%,p<0.001)。
  • TASC A/B组3年免截肢率(85% vs 67%,p=0.02)和免于主要不良肢体事件率(79% vs 61%,p=0.02)显著更高。
  • TASC A/B组技术成功率(95% vs 80%,p<0.001)和1年一期通畅率(58% vs 51%,p=0.04)更高。
  • 两组3年总生存率相似(96% vs 88%,p=0.2)。

关键数值与推荐

  • 再狭窄定义为随访1、3、6、12个月时双功超声收缩期峰值流速比>2.0。

临床怎么用

  • 对严重肢体缺血患者行膝下介入治疗时,TASC C/D病变需预期更高的截肢和主要不良肢体事件风险及更低一期通畅率。

局限性

  • 单中心回顾性设计可能限制结论的外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyze the relationship between the new TransAtlantic Inter-Society Consensus (TASC II) infrapopliteal classification and limb outcomes among patients with critical limb ischemia (CLI). METHODS: A single-center retrospective study was performed on 166 consecutive CLI patients (mean age 71 years; 113 men) undergoing endovascular treatment of 244 infrapopliteal lesions from 2006 to 2013. Patient, procedural, angiographic, and limb outcomes were compared for the new TASC A/B vs C/D classification for infrapopliteal lesions. Binary restenosis was determined by a peak systolic velocity ratio >2.0 by duplex ultrasound on follow-up at 1, 3, 6, and 12 months. RESULTS: Seventy-two (43.4%) patients had TASC A/B lesions, while 94 (56.6%) had TASC C/D patterns of infrapopliteal disease. Baseline demographics and tissue loss (93% vs 94%, p=0.59) were similar between the groups. TASC A/B lesions were shorter (53±35 vs 170±83 mm, p<0.001), less severely stenosed (77%±24% vs 93%±14%, p<0.001), had a larger target vessel diameter (2.9±0.5 vs 2.6±0.5 mm, p<0.001), and were less frequently chronic total occlusions (24% vs 64%, p<0.001) compared with the TASC C/D group. Three-year freedom from both amputation (85% vs 67%, p=0.02) and major adverse limb events (79% vs 61%, p=0.02) were significantly higher in the TASC A/B group. Technical success rates (95% vs 80%, p<0.001) and 1-year primary patency (58% vs 51%, p=0.04) were higher in the A/B group. Overall 3-year survival was similar between the groups (96% A/B vs 88% C/D, p=0.2). CONCLUSION: TASC C/D infrapopliteal lesions are associated with higher amputation and major adverse limb events rates and lower primary patency compared with TASC A/B infrapopliteal lesions. Further studies are needed to assess the association between TASC C/D infrapopliteal lesions and clinical outcomes in patients with CLI.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Singh GD, Brinza EK, Hildebrand J, et al. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries. J Endovasc Ther. 2017. PMID: 28421855. doi:10.1177/1526602817704643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。